首页> 外国专利> METHOD FOR PREVENTING AND(OR) TREATING ANEMIA IN CHILDREN (VARIANTS)

METHOD FOR PREVENTING AND(OR) TREATING ANEMIA IN CHILDREN (VARIANTS)

机译:预防和(或)治疗儿童(变种)贫血的方法

摘要

FIELD: medicine, pediatrics, hematology.;SUBSTANCE: the present innovation could be applied in treating surgical and oncological diseases in children during treating and preventing anemia of different etiology. One should introduce ceruloplasmin at daily single dosage ranged 50-200 mg depending upon child's age against 100-200 ml 0.9%-sodiumchloride solution intravenously by drops at the rate of 40-50 drops/min. Moreover, for preventing and/or treating posthemorrhagic anemia in case of surgical operations one should introduce ceruloplasmin during 2 d before surgical operation, intraoperationally, and for 2-10 d after operation. For preventing and/or treating anemia in case of purulent-septic diseases ceruloplasmin should be introduced during chemotherapeutic days during the whole period of the course conducted, for preventing and treating radiation anemia at the background of radiation therapy ceruloplasmin should be injected once weekly during the whole period of radiotherapy course, for preventing and treating toxic and radiation anemia at the background of chemoradiation therapy ceruloplasmin should be introduced once weekly on the day of chemotherapy during the whole course of chemoradiation treatment. The innovation enables to avoid inflows of erythrocytic mass and donor's blood along with shortened number of procedures on introduction of ceruloplasmin and 4-times decrease in the risk for the development of severe anemia in children due to matching peculiar mode for ceruloplasmin introduction.;EFFECT: higher efficiency of therapy and prophylaxis.;4 cl, 5 ex
机译:领域:医学,儿科,血液学;物质:本发明可用于治疗和预防不同病因性贫血期间儿童的手术和肿瘤疾病。一个人应根据孩子的年龄,以每天50-200 mg的单次剂量引入铜蓝蛋白,以40-50滴/分钟的速度静脉滴注100-200 ml 0.9%的氯化钠溶液。此外,为了在外科手术中预防和/或治疗失血后贫血,应在外科手术前2天,术中以及术后2-10天引入铜蓝蛋白。为了预防和/或治疗化脓性疾病而引起的贫血,应在整个疗程的化疗期间引入铜蓝蛋白,在放疗的背景下,为了预防和治疗放射性贫血,应在治疗期间每周注射一次铜蓝蛋白。在化学放疗的整个疗程中,为了预防和治疗在化学放疗的背景下的毒性和放射性贫血,应在化疗当天每天一次引入铜蓝蛋白。这项创新技术能够避免红血球团块和供血者的血液流入,同时缩短了引入铜蓝蛋白的程序的次数,并且由于采用了独特的铜蓝蛋白导入方式,使儿童患严重贫血的风险降低了4倍。更高的治疗和预防效率。; 4 cl,5 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号